RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
34.13
-0.60 (-1.73%)
Jan 15, 2026, 1:23 PM EST - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $945.77 million as of January 15, 2026. Its market cap has increased by 314.67% in one year.
Market Cap
945.77M
Enterprise Value
789.64M
1-Year Change
314.67%
Ranking
Category
Stock Price
$34.13
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $945.77M, an increase of 241.88%. That is a compound annual growth rate of 21.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 962.40M | 2.54% |
| Dec 31, 2025 | 938.57M | 340.16% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |